Wei Gao is an assistant professor at the University of Houston College of Pharmacy. Her research focuses on developing advanced nanomedicine and nanovaccine strategies for cancer immunotherapy. Specifically, she aims to modulate B cell and myeloid cell immunity using these strategies to enhance anticancer immunotherapy. Gao has been awarded NCI R01 grants for the period 2024-2029. Her work has resulted in 28 publications in prestigious journals such as Science Translational Medicine, ACS Nano, and Biomaterials, accumulating over 2,000 citations and an H-index of 19. Additionally, she has filed 9 PCT patents.